If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
120.50    1.50 (1.26%)
Bid:
119.00
Ask:
120.00
Spread: 1.00 (0.84%)
Market Cap: £94.56m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

IMS and Corporate Open Day

18 Oct 2012 07:00

RNS Number : 9481O
Xaar PLC
18 October 2012
 



 

 

 

FOR IMMEDIATE RELEASE

18 October 2012

 

 

 

Xaar plc

 

 

INTERIM MANAGEMENT STATEMENT AND CORPORATE OPEN DAY

 

 

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 July 2012.

 

Revenues for the third quarter of the year were in line with the Board's expectations. Sales continued to grow through the period, which resulted in a record revenue performance for the quarter. The Board continue to anticipate further growth in sales in the fourth quarter, with the outlook for full year revenue in line with expectations.

 

Gross margin in the third quarter was slightly higher than the margin achieved in the first half of the year, as production efficiencies from increased output more than offset the impact of the previously announced volume price discounts. Overall gross margin in the second half of 2012 is expected to be at least as strong as the first half of the year.

 

Operating profit in the third quarter benefited from the growth in both sales and gross margin although, as planned, the continued increase in investment in R&D resulted in a higher level of operating costs. The outlook for 2012 profitability continues to be in line with the Board's expectations.

 

The Group's balance sheet remains strong with net cash at 30 September 2012 of £18.8 million (30 June 2012: £15.7 million, 31 December 2011: £17.4 million).

 

On Tuesday, 23rd October 2012, Xaar is hosting an open day for investors and analysts at its Huntingdon manufacturing facility. The purpose of the event is to explain how Xaar's technology adds value in the end markets in which it operates, and to highlight the long term potential for digital inkjet. No new information will be presented.

 

END

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

James Irvine-Fortescue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSRILLDLIF
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.